Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European Stock Futures Higher; HSBC, UBS Post Quarterly Results

Published 26/04/2022, 07:16
Updated 26/04/2022, 07:16
© Reuters

By Peter Nurse 

Investing.com - European stock markets are expected to open higher Tuesday, rebounding to a degree from the previous session’s sharp losses, as investors digest key quarterly results from the banking sector. However, gains will be limited by concerns of slowing global growth and sharp monetary policy tightening.

At 2 AM ET (0600 GMT), the DAX futures contract in Germany traded 1.6% higher, CAC 40 futures in France climbed 1.6% and the FTSE 100 futures contract in the U.K. rose 1.1%.

European equity indices closed significantly lower Monday, with the DAX falling 1.5% and the CAC 40 just over 2%, but are expected to benefit Tuesday from the late revival on Wall Street, led by the tech-heavy Nasdaq Composite

Twitter (NYSE:TWTR) was a major focus as it finally confirmed it had accepted Elon Musk’s $44 billion offer to take the social media platform private. There are some significant earnings releases from the important sector this week, with both Alphabet (NASDAQ:GOOGL) and Microsoft (NASDAQ:MSFT) reporting after the close Tuesday.

Back in Europe, it’s the banking sector that will be to the fore, as lending giants HSBC (LON:HSBA) and UBS (SIX:UBSG) both published quarterly results.

HSBC, Europe’s largest bank, posted a pretax profit of $4.2 billion for the first quarter, ahead of market expectations but this still represented a 27% drop from a year ago. The lender also said further buybacks were unlikely this year, citing rising inflation and economic uncertainty due to the Russia-Ukraine conflict.

UBS fared better, posting a 17% rise in first-quarter net profit to $2.14 billion, beating expectations for a fall in profit amidst uncertainties over the war in Ukraine, thanks to strong trading.

Banco Santander (BME:SAN), Spain’s biggest lender, beat net income expectations in the first quarter, helped by growth in its lending revenue.

Elsewhere, Swiss drugmaker Novartis (SIX:NOVN) posted a 3% rise in core operating income, helped by sales growth from new drugs, while Orange (EPA:ORAN), France's biggest telecoms operator, said its first-quarter core operating profit grew 1%.

Still, sentiment remains fragile as the stringent lockdown in Shanghai, dragging into its fourth week, as well as the spreading of Covid-19 cases to other big Chinese cities like Beijing, is weighing on the economic growth outlook.

Additionally, investors remain concerned about whether the global economy can withstand the increasingly hawkish pivot from a number of key central banks, in particular the Federal Reserve.

Meanwhile, the war in Ukraine enters its third month, with Russian troops continuing to attack the Azovstal steel plant in the southeastern port city of Mariupol, where some 2,000 Ukrainian fighters are holding out. 

Oil prices rebounded Tuesday from the sharp losses of the previous session, but concerns remain that more Covid-19 lockdowns in China will hit demand for crude from the world’s largest importer.

By 2 AM ET, U.S. crude futures traded 1% higher at $99.56 a barrel, while the Brent contract rose 1.3% to $103.49. Both benchmarks dropped around 4% on Monday.

Additionally, gold futures rose 0.5% to $1,906.30/oz, while EUR/USD traded 0.1% higher at 1.0726.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.